MGI Tech Co., Ltd. (referred to as MGI) is committed to building core tools and technology to lead life science through intelligent innovation. MGI focuses on R&D, production and distribution of DNA sequencing instruments, reagents, and related products to support life science research, agriculture, precision medicine and healthcare. MGI is a leading producer of clinical high-throughput gene sequencers, and its multi-omics platforms include genetic sequencing, medical imaging, and laboratory automation.

​

As of June 30, 2021, MGI has 1,859 employees, and 34% of whom are R&D personnel. Founded in 2016, MGI operates in more than 70 countries and regions, serving more than 1000 customers. It has established scientific research and production bases, global training and service networks in many countries and regions around the world. MGI is one of the companies in the world that have the ability to independent develop and mass-produce clinical high-throughput gene sequencers. Providing real-time, comprehensive, lifelong solutions, its vision is to lead life science innovation.

​

Neoscience is proudly appointed by MGI starting January 1st, 2021 to be MGI’s Only and Preferred Partner in Malaysia.